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Abstract: Lymphomatous involvement of the airway causing stridor
is a rare but frightening presentation of an eminently treatable
condition. We describe a 24-year-old woman with tracheal non-
Hodgkin lymphoma who was initially diagnosed with asthma, but
subsequently presented with near-fatal acute upper airway obstruc-
tion because of a tracheal Anaplastic Lymphoma Kinase (ALK)
anaplastic T-cell lymphoma. The obstructing tumor was extricated
by means of rigid bronchoscopy. After six cycles of Cyclophosph-
amide, Doxorubicin, Vincristine, Prednisolone chemotherapy, the
patient went into complete clinical remission. A high index of
suspicion in patients with dyspnoea and wheeze unresponsive to
bronchodilators is crucial in early diagnosis of tracheal tumors.
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Primary malignant neoplasms of the trachea are rare, ac-counting for 0.1 to 0.4% of all malignancies. They often
present late, because the tumors usually do not cause symp-
toms until they occlude 50 to 75% of the luminal diameter,
with exertional dyspnoea ensuing only when the tracheal
lumen is narrowed to less than 7 mm.1 Furthermore, they
mimic common conditions like chronic obstructive pulmo-
nary disease or asthma, and delayed diagnosis of more than 6
months after symptoms onset occurs in up to one third of
patients.1
Our patient was a 24-year-old woman who complained
of a 4-month history of dry cough and progressive dyspnoea
associated with rhonchi. A clinical diagnosis of asthma was
made, and she was treated with salbutamol and corticoste-
roid-containing inhalers, with minimal improvement of
symptoms. No pulmonary function tests were done. Because
of unremitting symptoms, a computed tomography scan was
performed, revealing a right paratracheal mass with endo-
bronchial extension and obstruction in both the trachea and
right main bronchus (Figure 1). The patient was subsequently
transferred to our institution the following day for further
management.
On arrival late that evening, she was acutely dyspnoeic
and in respiratory distress, with widespread rhonchi and
stridor. Chest radiograph showed complete collapse of only
the right lung (Figure 2). Nevertheless, ensuing fatigue and
acute desaturation prompted intubation and mechanical ven-
tilation, paradoxically worsening her hypoxia, resulting in
cardiorespiratory arrest. After successful resuscitation, emer-
gency flexible bronchoscopy confirmed near-total occlusion
of the trachea by an intraluminal polyp (Figure 3). The patient
was then taken to the operating room for rigid bronchoscopy
under general anesthesia. In the operating room, the endotra-
cheal tube was removed before advancement of the rigid
bronchoscope into the tracheal lumen, and the tumor cored-
out with the bevelled tip. Neodymium:yttrium-argon-garnet
laser was used for hemostasis. Histology revealed anaplastic
ALK T-cell lymphoma, with diffuse sheets of large round
cells staining positive for CD30 and ALK, and negative for
CD3, CD20, and cytokeratin markers. Further staging inves-
tigations confirmed Stage IE (extranodal) non-Hodgkin lym-
phoma (NHL), for which CHOP chemotherapy was instituted
(D1 cyclophosphamide 750 mg/m2, D1 doxorubicin 50 mg/
m2, D1 vincristine 1.4 mg/m2, D1 to D5 prednisolone 40
mg/m2, cycled every 14 days). After completing six cycles of
chemotherapy, the patient was offered consolidative in-
volved-field radiotherapy but declined because of personal
reasons. Follow-up imaging revealed complete clinical and
radiologic response and the patient remains in remission 1
year later.
Primary tracheal lymphomas originate from mesenchy-
mal B and T cells probably involved in immunosurveillance
of the upper airways.1 In a case series of primary tracheal
tumors from Taiwan, lymphomas comprised 3% of the co-
hort.2 Indeed even in a large historical series of extranodal
NHL, only 3.6% presented with involvement of the pulmo-
nary parenchyma or tracheobronchial tree as the primary site
of disease.3 Common presenting symptoms include dyspnoea
(50%), cough (42%), wheezing (19%), and at later stages,
stridor (1%).4 Failure to respond to bronchodilators should
arouse suspicion of a tracheal tumor. Computed tomography
imaging and bronchoscopy are diagnostic. Pulmonary func-
tion tests, in the cooperative and well patient, may show
variable intra/extrathoracic obstruction, or in this patient’s
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case, fixed upper airway obstruction, with flattening of both
inspiratory and expiratory phases of the flow-volume loops.
Stridor caused by obstructing tracheal lymphoma tu-
mors, is a rare but frightening presentation of a treatable
condition if addressed promptly. Emergent bronchoscopic
assessment of the oropharynx down to the upper bronchial
tree, with available expertise for intervention to relief ob-
structing objects, is paramount. Endotracheal intubation with-
out prior visual assessment of the upper airways could dis-
lodge tumors, or blind end within the tumor, and cause
massive hemorrhage. Moreover, because of reduced effi-
ciency of mechanical ventilation (as compared with normal
ventilation), a ball-valve effect can occur and further com-
promise airway patency, causing paradoxical hypoxia.
Primary tracheal malignancies tend to present insidi-
ously, and can be rapidly fatal once catastrophic airway
obstruction supervenes. Pulmonary function tests with flow-
volume curves at initial presentation may be useful in dis-
criminating such tumors from asthma or chronic obstructive
pulmonary disease. It is important for respiratory physicians,
thoracic surgeons, and oncologists to consider NHL as a
differential for an obstructing airway tumor, because timely
management can yield favorable long-term outcomes.
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FIGURE 1. Coronal section of the computed tomography
chest demonstrating the tracheal lymphoma.
FIGURE 2. Chest radiograph showing complete collapse
of right lung (done 2 days after the computed tomogra-
phy chest).
FIGURE 3. Bronchoscopic view of the tumor causing near-
total occlusion of the tracheal lumen.
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